Previous Section Index Home Page


19 Sept 2002 : Column 422W—continued

Reproductive Health Programmes

Angus Robertson: To ask the Secretary of State for International Development, pursuant to her answer of 25 February 2002, Official Report, columns 883–886W, how much money her Department has given in support of the Russian Family Planning Association per annum since 1997; what that represents in percentage terms of her Department's per annum expenditure for population

19 Sept 2002 : Column 423W

reproductive health programmes; if she will explain the makeup of the Russian Family Planning Association; and if she will make a statement. [73183]

Clare Short: My Department funded the International Planned Parenthood Federation's (IPPF) European Network to provide technical assistance to the Russian Family Planning Association (RFPA) from March 1995 to June 2002. The purpose of our support has been to ensure that accurate information about reproductive health is disseminated in Russia, through the leadership of the RFPA. The total value of funding provided to IPPF during this period has been £390,000, over two project phases. Annual expenditure since 1997 has been as follows:


19 Sept 2002 : Column 424W

My Department spent approximately £206 million on sexual and reproductive health in financial year 2001–02. My Department's expenditure on this project in that year therefore represents less than 0.07 per cent. of annual expenditure. The RFPA is a non-governmental organisation, based in Moscow. My Department reviewed this project in January 2002 and concluded that its purpose was likely to be largely achieved. No further assistance to the RFPA is planned.

Angus Robertson: To ask the Secretary of State for International Development, pursuant to her answer of 25 February 2002, Official Report, columns 883–886W, how much money her Department has given to the (a) health and sexual education programme in Bolivia since 1997 and (b) Orissa Reproductive Health Project in India in each year since 1997; what these amounts represent in percentage terms of her Department's per annum expenditure for population reproductive health programmes; and if she will make a statement. [73172]

Clare Short: My Department has spent the following amounts on each project listed since 1997. Expenditure has also been expressed as a percentage of DFID's annual spend on sexual and reproductive health activities in each year;

£ actuals1997–981998–991999–20002000–01
Spend% of annual
Reproductive
Health spend
Spend
% of annual
Reproductive
Health spend
Spend% of annual
Reproductive
Health spendSpend% of annual
Reproductive
Health spend
Health and Sexual Education
Programme, Bolivia629,9431.6482,4581.1718,9400.91,162,0100.9
Orissa Reproductive Health
Project, India287,3860.7475,2141.1409,7650.5422,4280.3


Angus Robertson: To ask the Secretary of State for International Development, pursuant to her answer of 25 February 2002, Official Report, columns 883–886W, how much money her Department has given to (a) the reproductive health programme in Peru, (b) the STD programme in the Russian Federation and (c) the Central American regional programme for improving sexual and reproductive health services in each year since 1997; what these amounts represent in percentage terms of her Department's per annum expenditure for population reproductive health programmes; and if she will make a statement. [73184]

Clare Short: My Department has spent the following amounts on each of the programmes listed since 1997. Expenditure has also been expressed as a percentage of DFID's annual spend on sexual and reproductive health activities in each year;

1997–981998–991999–20002000–01
£ actualsValue% of Annual
Reproductive
Health SpendValue% of Annual
Reproductive
Health SpendValue% of Annual
Reproductive
Health SpendValue% of Annual
Reproductive
Health Spend
Reproductive Health
Programme, Peru1,020,1902.61,034,0112.3966.6771.3533,9480.4
STD Programme, Russian
Federation--388,7070.8150,0190.2207,8960.2
Central American Regional
Programme on Sexual and
Reproductive Health------323,1700.2

Radioactive Floodwaters

Mr. Cousins: To ask the Secretary of State for International Development what recent reports she has received for assistance for containing radioactive floodwaters in Kyrgystan and Uzbekistan; and how she proposes to respond to them. [61860]

Clare Short: No reports have been received, but my Officials have recently obtained a World Bank commissioned technical assessment on landslide and uranium tailings problems and options for remediation in Kyrgyzstan. My Department has not been asked to respond to the technical assessment.

Lebanon

Mr. Love: To ask the Secretary of State for International Development what recent assistance she has given to the Government of Lebanon for the re-building of its infrastucture; and if she will make a statement. [73016]

19 Sept 2002 : Column 425W

Clare Short: My Department has a very small bilateral development assistance programme in Lebanon. We contribute to multilateral institutions (including the World Bank, IMF and EC) which are implementing larger programmes in Lebanon. The Government of Lebanon would be able to raise any issue of concern with these institutions directly.

Biotechnology Research Projects

Alan Simpson: To ask the Secretary of State for International Development what biotechnology research projects in (a) agriculture and (b) biomedics have been supported by her Department; and what public investment has gone into them in each of the last three years. [73238]

Clare Short: Separate data are not maintained of the many projects using biotechnology techniques for research purposes.

Biotechnology research projects in agriculture and related disciplines involving the potential release of genetically modified organisms in developing countries, and studies on genetic modification issues, are listed on the DFID website www.dfid.gov.uk. Expenditure on these projects in the last three years was: 1999–2000 £645,136; 2000–01 £767,479; 2001–02 £873,516.

A briefing note on genetically modified organisms and developing countries is also on the website.

DFID invests in biomedical research to develop new drugs, vaccines and other products to prevent disease in developing countries.

Since 2001, £1.5 million has been invested in the International AIDS Vaccine Initiative. The Medicines for Malaria Venture has been given £1 million a year over the last three years to expedite discovery of the next generation of anti-malarial drugs.

Through the UK Medical Research Council (MRC), DFID began funding a five year £16 million Microbicides Development Programme in the current financial year. In addition, DFID's concordat with the MRC involves a contribution in excess of £4 million a year to their research portfolio which includes basic biomedical research relevant to the health of poor people in developing countries.

DFID's contribution of about £10 million a year to the World Health Organisation includes funds for its tropical diseases research programme. This funding is not earmarked and data are not available of the exact sums going to the programme and the amounts used for biomedical research.

EU Committees

Angus Robertson: To ask the Secretary of State for International Development when the EU Committee for the implementation of the Regulation establishing an Instrument for Structural Policies for Pre-accession is next due to meet; whether representatives of the Scottish Executive (a) have been and (b) are members of it; and if she will make a statement. [73160]

19 Sept 2002 : Column 426W

Clare Short: The next meeting of the EU Committee of the Instrument for Structural Policies for Pre-accession (ISPA) is due to take place in October 2002; the exact date has yet to be decided.

Schedule 5 of the 1998 Scottish Act sets out areas of policy that are reserved, that is, where responsibility has not been devolved to the Scottish Executive. Section 7 (1) of Schedule 5 states:


The United Kingdom is represented on the ISPA Committee by officials from the Department for International Development and the United Kingdom Permanent Representation to the European Commission.


Next Section Index Home Page